Richard Heinzl

Executive

Onco-Innovations Limited ASEP Medical Holdings Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 1 saleFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€2,088

Latest filing published 20 Oct 2026 for ASEP Medical Holdings Inc..

Filing timeline

BuySale

Richard Heinzl

Insider track record

Disclosed buys

Disclosed sells

Signal history

Richard Heinzl: trading record in brief

Richard Heinzl has filed trades across 2 companies (mainly through SEDI), most often in Onco-Innovations Limited and ASEP Medical Holdings Inc. Between 12 September 2023 and 29 September 2026, the trades on record add up to 13 filings.

On the market, this insider has only sold: 1 sale, €2,088 in total. Besides market trades, the filings include 1 share grant and 2 option exercises. So far in 2026, the count stands at no purchases and 1 sale.

The newest entry dates from 20 October 2026: a transaction, in ASEP Medical Holdings Inc. The median gap between a trade and its publication by SEDI is 1 day. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEDI disclosures alone and does not predict where the share price will go.